ST金花(600080.SH)2020年度净利润预增88%到118%
格隆汇 1 月 22日丨ST金花(600080.SH)公布,公司2020年年度实现归属于上市公司股东的净利润与上年同期相比,预计增加2287万元到3062万元,同比增加88%到118%;扣除上述非经常性损益事项后,公司业绩预计增加2563万元到2968万元,同比增加192%到222%。
本期业绩预增的主要原因:(一)主营业务影响:1、公司医药工业板块受疫情影响市场投入费用降低;2、公司积极控制成本减少开支;3、报告期内,公司控股股东归还占用资金,冲回大额坏账。
非经营性损益的影响:非经常性损益对公司业绩预增没有重大影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.